-
Electronic (PDF)
-
Site License
-
Enterprisewide
Scil Technology Gmbh - Product Pipeline Analysis
GlobalData, October 2011, Pages: 23
Scil Technology Gmbh - Product Pipeline Analysis
Summary
Scil Technology Gmbh (Scil) is a biopharmaceutical drug development company that provides orthopedic and dental tissue regeneration materials with a focus on bone and cartilage repair. The products developed by the company are related to dentistry and orthopedics such as dental bone substitute materials, coated dental implants and bone substitute materials. The company serves these products for dental implantology, periodontal disease, critical implantation sites, spinal fusion, osteochondral defects and osteoarthritis. It also offers a unique proprietary protein coating technology for the combination of biomaterials for homogeneous loading of proteins onto the surface of biomaterials.
This report is a source for data, analysis and actionable intelligence on the Scil Technology Gmbh portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
List of Tables
List of Figures
Key Facts
Scil Technology Gmbh - Major Products and Services
Scil Technology Gmbh Pipeline Products by Equipment Type
Scil Technology Gmbh Pipeline Products by Development Stage
Scil Technology Gmbh Pipeline Products by Therapy Area
Scil Technology Gmbh Pipeline Products by Trial Phase
MD05-I
Product Status
Product Description
MD05-P Bone Graft Substitute Material
Product Status
Product Description
Product Milestone
MD05-P Bone Graft Substitute Material Clinical Trial
Product Patent Details
MD06 Activated Implant
Product Status
Product Description
MD08 Injectable Paste
Product Status
Product Description
ST01 Bone Graft Substitute Material
Product Status
Product Description
ST03 Activated Implant
Product Status
Product Description
Product Patent Details
ST04 Activated Injectable
Product Status
Product Description
ST05
Product Status
Product Description
Scil Technology Gmbh - Key Competitors
Scil Technology Gmbh - Key Employees
Scil Technology Gmbh - Locations And Subsidiaries
Head Office
Recent Developments
Jul 20, 2011: Scil Technology Establishes Independent Service Unit Formycon
Jun 23, 2011: Scil Technology Receives Public Research Grant For New Rheumatoid Arthrits Treatments
Feb 14, 2011: Scil Technology Appoints Christian Nafe As CEO
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Scil Technology Gmbh, Key Facts
Scil Technology Gmbh Key Pipeline Products by Equipment Type
Scil Technology Gmbh Key Pipeline Products by Therapy Area
Scil Technology Gmbh Key Pipeline Products by Development Stage
Scil Technology Gmbh Key Pipeline Products by Trial Phase
Scil Technology Gmbh, Key Facts
Scil Technology Gmbh, Major Products and Services
Scil Technology Gmbh Number of Pipeline Products by Equipment Type
Scil Technology Gmbh Pipeline Products by Equipment Type
Scil Technology Gmbh Number of Pipeline Products by Development Stage
Scil Technology Gmbh Pipeline Products by Development Stage
Scil Technology Gmbh Number of Pipeline Products by Therapy Area
Scil Technology Gmbh Pipeline Products by Therapy Area
Scil Technology Gmbh Number of Pipeline Products by Trial Phase
Scil Technology Gmbh Pipeline Products by Trial Phase
MD05-I - Product Status
MD05-I - Product Description
MD05-P Bone Graft Substitute Material - Product Status
MD05-P Bone Graft Substitute Material - Product Description
MD05-P Bone Graft Substitute Material - Product Milestone
MD05-P Bone Graft Substitute Material - Pilot Study on Safety and Efficacy of MD05 in Comparison With Beta-TCP in Patients Undergoing Sinus Floor Augmentation
MD05-P Bone Graft Substitute Material - Pilot Study on Safety and Explorative Efficacy of MD05 in Comparison With Open Flap Debridement in Patients Undergoing Periodontal Surgery to Treat Deep Intrabony Defects
MD05-P Bone Graft Substitute Material - Patent Details
MD06 Activated Implant - Product Status
MD06 Activated Implant - Product Description
MD08 Injectable Paste - Product Status
MD08 Injectable Paste - Product Description
ST01 Bone Graft Substitute Material - Product Status
ST01 Bone Graft Substitute Material - Product Description
ST03 Activated Implant - Product Status
ST03 Activated Implant - Product Description
ST03 Activated Implant - Patent Details
ST04 Activated Injectable - Product Status
ST04 Activated Injectable - Product Description
ST05 - Product Status
ST05 - Product Description
Scil Technology Gmbh, Key Employees
List of Figures
Scil Technology Gmbh Key Pipeline Products by Equipment Type
Scil Technology Gmbh Pipeline Products by Equipment Type
Scil Technology Gmbh Pipeline Products by Development Stage
Scil Technology Gmbh Pipeline Products by Therapy Area
Scil Technology Gmbh Pipeline Products by Trial Phase
Zepf Medical Instruments GmbH
Wassermann Zahntechnik Gmbh
Alpha Dental Technik GmbH
MIS Implant Technologies Ltd
Antweiler Zahntechnik Gmbh
BTI Biotechnology Institute S.L.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
